PMID- 30386956
OWN - NLM
STAT- MEDLINE
DCOM- 20190423
LR  - 20200225
IS  - 1875-8312 (Electronic)
IS  - 1569-5794 (Linking)
VI  - 35
IP  - 3
DP  - 2019 Mar
TI  - A propensity score matched valuation on feasibility of low frame rate fluoroscopy 
      during primary percutaneous coronary intervention for patients with STEMI.
PG  - 393-399
LID - 10.1007/s10554-018-1475-1 [doi]
AB  - The present study aimed to evaluate the feasibility of low frame rate fluoroscopy 
      during primary percutaneous coronary intervention (PPCI) for patients with acute 
      ST elevation myocardial infarction (STEMI). From January 2016 to December 2017, 
      165 consecutive patients with STEMI who underwent PPCI were retrospectively 
      divided into two groups: the 7.5-frame group (fluoroscopy at 7.5 frames/s) and 
      the 15-frame group (fluoroscopy at 15 frames/s), according to the frame rate of 
      fluoroscopy used in their treatment. Reduction of radiation and safety of 
      fluoroscopy at 7.5 frames/s were compared by a method of propensity score 
      matching (PSM) with fluoroscopy at 15 frames/s. After PSM, there were 56 patients 
      in each group. There were no differences in patients' baseline characteristics 
      between two groups. The 7.5-frame protocol resulted in 48.9% reduction of DAP 
      (9917 +/- 5543 cGycm(2) vs. 14766 +/- 7272 cGycm(2), P < 0.001) and 61.1% reduction 
      of AK (1209 +/- 562 mGy vs. 1948 +/- 1105 mGy, P < 0.001) with comparable procedural 
      time (38.1 +/- 15.3 min vs. 38.8 +/- 17.2 min, P = 0.830), fluoroscopy time 
      (13.0 +/- 7.2 min vs. 13.5 +/- 8.1 min, P = 0.703) and contrast volume 
      (122.3 +/- 39.4 ml vs. 119.3 +/- 49.4 ml, P = 0.725) to the 15-frame group. 
      Meanwhile, this new protocol didn't increase the incidence of contrast-induced 
      nephropathy (23.2% vs. 25.0%, OR = 0.907, 95% CI 0.381-2.157, P = 0.825) and 
      peri-PPCI cumulative adverse events (30.4% vs. 28.6%, OR = 1.090, 95% CI 
      0.483-2.456, P = 0.836). In conclusion, low frame rate fluoroscopy at 
      7.5 frames/s is a safe and feasible strategy for reducing radiation during PPCI.
FAU - Fan, Lin
AU  - Fan L
AUID- ORCID: 0000-0002-6270-0278
AD  - Department of Cardiology, Institute of Coronary Heart Disease, Fujian Medical 
      University Union Hospital, Xinquan Road 29#, Fuzhou, 350001, Fujian, China. 
      rickfan7587@hotmail.com.
FAU - Luo, Yukun
AU  - Luo Y
AD  - Department of Cardiology, Institute of Coronary Heart Disease, Fujian Medical 
      University Union Hospital, Xinquan Road 29#, Fuzhou, 350001, Fujian, China.
FAU - Chen, Zhaoyang
AU  - Chen Z
AD  - Department of Cardiology, Institute of Coronary Heart Disease, Fujian Medical 
      University Union Hospital, Xinquan Road 29#, Fuzhou, 350001, Fujian, China.
FAU - Cai, Wei
AU  - Cai W
AD  - Department of Cardiology, Institute of Coronary Heart Disease, Fujian Medical 
      University Union Hospital, Xinquan Road 29#, Fuzhou, 350001, Fujian, China.
FAU - Dong, Xianfeng
AU  - Dong X
AD  - Department of Cardiology, Institute of Coronary Heart Disease, Fujian Medical 
      University Union Hospital, Xinquan Road 29#, Fuzhou, 350001, Fujian, China.
FAU - Lin, Chaogui
AU  - Lin C
AD  - Department of Cardiology, Institute of Coronary Heart Disease, Fujian Medical 
      University Union Hospital, Xinquan Road 29#, Fuzhou, 350001, Fujian, China.
FAU - Chen, Lianglong
AU  - Chen L
AD  - Department of Cardiology, Institute of Coronary Heart Disease, Fujian Medical 
      University Union Hospital, Xinquan Road 29#, Fuzhou, 350001, Fujian, China.
LA  - eng
GR  - 81670330/National natural science foundation of China/
GR  - 2016J1545/Natural science foundation of Fujian Province/
PT  - Comparative Study
PT  - Journal Article
PT  - Observational Study
DEP - 20181101
PL  - United States
TA  - Int J Cardiovasc Imaging
JT  - The international journal of cardiovascular imaging
JID - 100969716
SB  - IM
MH  - Aged
MH  - Feasibility Studies
MH  - Female
MH  - Fluoroscopy
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - *Percutaneous Coronary Intervention/adverse effects
MH  - Propensity Score
MH  - Radiation Dosage
MH  - Radiation Exposure/adverse effects/*prevention & control
MH  - Radiography, Interventional/adverse effects/*methods
MH  - Retrospective Studies
MH  - Risk Assessment
MH  - Risk Factors
MH  - ST Elevation Myocardial Infarction/diagnostic imaging/*surgery
MH  - Time Factors
MH  - Treatment Outcome
OTO - NOTNLM
OT  - Fluoroscopy
OT  - Percutaneous coronary intervention
OT  - Radiation
OT  - ST elevation myocardial infarction
EDAT- 2018/11/06 06:00
MHDA- 2019/04/24 06:00
CRDT- 2018/11/03 06:00
PHST- 2018/07/11 00:00 [received]
PHST- 2018/10/13 00:00 [accepted]
PHST- 2018/11/06 06:00 [pubmed]
PHST- 2019/04/24 06:00 [medline]
PHST- 2018/11/03 06:00 [entrez]
AID - 10.1007/s10554-018-1475-1 [pii]
AID - 10.1007/s10554-018-1475-1 [doi]
PST - ppublish
SO  - Int J Cardiovasc Imaging. 2019 Mar;35(3):393-399. doi: 10.1007/s10554-018-1475-1. 
      Epub 2018 Nov 1.